News & Event

UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19

  • Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
  • Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
  • Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
  • No adverse events were recorded in the group
  • Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately

“Read More”

Leave a Reply

Your email address will not be published. Required fields are marked *